Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	EP400 CHD3 CHD7	1.77e-04	37	59	3	GO:0140658
GeneOntologyMolecularFunction	fatty acid elongase activity	ELOVL3 ELOVL2	1.79e-04	7	59	2	GO:0009922
GeneOntologyMolecularFunction	chromatin binding	ARID1B EP400 PPP2R3B MLLT3 CHD3 CHD7 MED1 LCOR HCFC1	2.97e-04	739	59	9	GO:0003682
GeneOntologyMolecularFunction	nuclear estrogen receptor binding	MED1 PIAS2 LCOR	5.17e-04	53	59	3	GO:0030331
Domain	DNA/RNA_helicase_DEAH_CS	EP400 CHD3 CHD7 DHX33	4.37e-06	35	59	4	IPR002464
Domain	DEAH_ATP_HELICASE	EP400 CHD3 CHD7 DHX33	6.12e-06	38	59	4	PS00690
Domain	SNF2_N	EP400 CHD3 CHD7	1.39e-04	32	59	3	IPR000330
Domain	SNF2_N	EP400 CHD3 CHD7	1.39e-04	32	59	3	PF00176
Domain	ELO_CS	ELOVL3 ELOVL2	1.46e-04	6	59	2	IPR030457
Domain	ELO	ELOVL3 ELOVL2	2.04e-04	7	59	2	PF01151
Domain	ELO	ELOVL3 ELOVL2	2.04e-04	7	59	2	PS01188
Domain	ELO_fam	ELOVL3 ELOVL2	2.04e-04	7	59	2	IPR002076
Domain	FN3	MYLK PTPRG MERTK HCFC1 CNTN1	2.93e-04	185	59	5	SM00060
Domain	Helicase_C	EP400 CHD3 CHD7 DHX33	3.64e-04	107	59	4	PF00271
Domain	HELICc	EP400 CHD3 CHD7 DHX33	3.64e-04	107	59	4	SM00490
Domain	Helicase_C	EP400 CHD3 CHD7 DHX33	3.77e-04	108	59	4	IPR001650
Domain	HELICASE_CTER	EP400 CHD3 CHD7 DHX33	3.90e-04	109	59	4	PS51194
Domain	HELICASE_ATP_BIND_1	EP400 CHD3 CHD7 DHX33	3.90e-04	109	59	4	PS51192
Domain	DEXDc	EP400 CHD3 CHD7 DHX33	3.90e-04	109	59	4	SM00487
Domain	Helicase_ATP-bd	EP400 CHD3 CHD7 DHX33	4.04e-04	110	59	4	IPR014001
Domain	FN3	MYLK PTPRG MERTK HCFC1 CNTN1	4.10e-04	199	59	5	PS50853
Domain	FN3_dom	MYLK PTPRG MERTK HCFC1 CNTN1	5.13e-04	209	59	5	IPR003961
Domain	fn3	MYLK PTPRG MERTK CNTN1	1.71e-03	162	59	4	PF00041
Domain	Chromo_domain	CHD3 CHD7	2.59e-03	24	59	2	IPR023780
Domain	Chromo	CHD3 CHD7	3.04e-03	26	59	2	PF00385
Domain	CHROMO_1	CHD3 CHD7	3.52e-03	28	59	2	PS00598
Domain	CHROMO_2	CHD3 CHD7	3.52e-03	28	59	2	PS50013
Domain	Chromodomain-like	CHD3 CHD7	4.58e-03	32	59	2	IPR016197
Domain	Chromo/shadow_dom	CHD3 CHD7	4.86e-03	33	59	2	IPR000953
Domain	CHROMO	CHD3 CHD7	4.86e-03	33	59	2	SM00298
Domain	P-loop_NTPase	EP400 GAL3ST1 KIF26B CHD3 CHD7 DHX33 NUBPL MYO16	4.98e-03	848	59	8	IPR027417
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	ELOA ILF3 EP400 MAP4 WDR70 RPRD2 CHD3 CHD7 MED1 PIAS2 HCFC1	2.49e-12	283	61	11	30585729
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	TLK2 ILF3 EP400 MAP4 AHNAK WDR70 MED1 PIAS2 HCFC1 AHNAK2	5.24e-09	444	61	10	34795231
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	ELOA ARID1B ILF3 EP400 MAP4 AHNAK RPRD2 CHD3 PRPF6 CHD7 MED1 LCOR HCFC1	8.92e-09	954	61	13	36373674
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	ELOA ILF3 MAP4 AHNAK RPRD2 CHD3 DENND4C AHNAK2	5.25e-08	298	61	8	30737378
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ELOA ILF3 SMG7 EP400 MAP4 AHNAK WDR70 RPRD2 CHD3 MED1 HCFC1 AHNAK2	6.82e-08	934	61	12	33916271
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	EP400 MAP4 AHNAK CHD3 PRPF6 PIAS2 HCFC1 AHNAK2	1.20e-07	332	61	8	32786267
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	MAP4 KIF26B AHNAK CHD3 HCFC1 DENND4C AHNAK2	3.35e-07	256	61	7	33397691
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	ARID1B EP400 CHD3 CHD7 MED1	3.67e-07	83	61	5	28794006
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	TLK2 ARID1B ILF3 EP400 MAP4 CHD3 PRPF6 CHD7 MED1 QKI LCOR HCFC1	4.05e-07	1103	61	12	34189442
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	ARID1B EP400 RPRD2 CHD3 CHD7 MED1 HCFC1	4.56e-07	268	61	7	33640491
Pubmed	Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing.	ILF3 EP400 AHNAK RPRD2 CHD3 MED1 HCFC1	4.92e-07	271	61	7	32433965
Pubmed	Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism.	ARID1B ILF3 EP400 CHD3 PRPF6 MED1 HCFC1	2.27e-06	341	61	7	32971831
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	TLK2 ELOA EP400 RPRD2 PRPF6 HCFC1	2.62e-06	222	61	6	37071664
Pubmed	Role of transverse bands in maintaining paranodal structure and axolemmal domain organization in myelinated nerve fibers: effect on longevity in dysmyelinated mutant mice.	GAL3ST1 QKI	3.03e-06	2	61	2	20506478
Pubmed	The AHNAKs are a class of giant propeller-like proteins that associate with calcium channel proteins of cardiomyocytes and other cells.	AHNAK AHNAK2	3.03e-06	2	61	2	15007166
Pubmed	AHNAK1 and AHNAK2 are costameric proteins: AHNAK1 affects transverse skeletal muscle fiber stiffness.	AHNAK AHNAK2	3.03e-06	2	61	2	20833135
Pubmed	Diagnostic and prognostic value of STAP1 and AHNAK methylation in peripheral blood immune cells for HBV-related hepatopathy.	AHNAK STAP1	3.03e-06	2	61	2	36713363
Pubmed	ELOVL2 overexpression enhances triacylglycerol synthesis in 3T3-L1 and F442A cells.	ELOVL3 ELOVL2	3.03e-06	2	61	2	17583696
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ELOA ILF3 EP400 MAP4 AHNAK CHD3 PRPF6 CHD7 MED1 NUBPL QKI HCFC1	3.90e-06	1371	61	12	36244648
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	ARID1B EP400 RPRD2 MED1 HCFC1	3.94e-06	134	61	5	25452129
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	TLK2 ILF3 SMG7 MAP4 AHNAK SEC31A MED1 LCOR AHNAK2	4.61e-06	724	61	9	36232890
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	ELOA ARID1B EP400 WDR70 RPRD2 CHD7 KIAA1191 HCFC1 DENND4C	5.09e-06	733	61	9	34672954
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	ARID1B SMG7 EP400 MAP4 AHNAK RPRD2 MED1 HCFC1	5.18e-06	549	61	8	38280479
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	ILF3 AHNAK RPRD2 SEC31A MED1 QKI HCFC1	6.35e-06	399	61	7	35987950
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	ARID1B EP400 MLLT3 CHD3 CHD7	8.53e-06	157	61	5	30186101
Pubmed	Self-regulated alternative splicing at the AHNAK locus.	AHNAK AHNAK2	9.07e-06	3	61	2	21940993
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	ELOA ILF3 EP400 MAP4 AHNAK WDR70 CHD3 PRPF6 MED1 HCFC1	9.94e-06	1014	61	10	32416067
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	ILF3 EP400 AHNAK RPRD2 CHD3 PRPF6 CHD7 DHX33 MED1 LCOR HCFC1	1.37e-05	1294	61	11	30804502
Pubmed	A functional interaction between RHA and Ubc9, an E2-like enzyme specific for Sumo-1.	ILF3 PIAS2	1.81e-05	4	61	2	15312759
Pubmed	AHNAK, a novel component of the dysferlin protein complex, redistributes to the cytoplasm with dysferlin during skeletal muscle regeneration.	AHNAK AHNAK2	1.81e-05	4	61	2	17185750
Pubmed	The protein tyrosine phosphatases PTPRZ and PTPRG bind to distinct members of the contactin family of neural recognition molecules.	PTPRG CNTN1	1.81e-05	4	61	2	20133774
Pubmed	Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids.	ELOVL3 ELOVL2	1.81e-05	4	61	2	10970790
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	ILF3 MAP4 RPRD2 MED1 HCFC1 DENND4C STAP1	2.82e-05	503	61	7	16964243
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	ELOA ARID1B EP400 RPRD2 PIAS2 HCFC1	2.90e-05	339	61	6	30415952
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	ILF3 MAP4 AHNAK RPRD2 PRPF6 HCFC1	2.95e-05	340	61	6	24332808
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	ARID1B ILF3 SMG7 MAP4 CHD3 PRPF6 CHD7 MED1 YES1 HCFC1	2.99e-05	1153	61	10	29845934
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	PRPSAP1 PTPRG MTFR1 CHD7 SEC31A PIAS2 LCOR	4.22e-05	536	61	7	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	PRPSAP1 PTPRG MTFR1 CHD7 SEC31A PIAS2 LCOR	4.32e-05	538	61	7	10512203
Pubmed	The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator.	MED1 HCFC1	4.52e-05	6	61	2	14983011
Pubmed	Postsynaptic CaV1.1-driven calcium signaling coordinates presynaptic differentiation at the developing neuromuscular junction.	PCLO RYR1	4.52e-05	6	61	2	31804576
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TLK2 ELOA ILF3 EP400 MAP4 CHD3 CHD7 MED1	6.04e-05	774	61	8	15302935
Pubmed	Association of the nucleocapsid protein of the Seoul and Hantaan hantaviruses with small ubiquitin-like modifier-1-related molecules.	CHD3 PIAS2	6.32e-05	7	61	2	14609633
Pubmed	SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action.	AHNAK AHNAK2	6.32e-05	7	61	2	23415230
Pubmed	An improved smaller biotin ligase for BioID proximity labeling.	ARID1B MAP4 HCFC1 AHNAK2	6.65e-05	123	61	4	26912792
Pubmed	WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage.	EP400 AHNAK CHD3 PRPF6 CHD7 MED1	6.68e-05	394	61	6	27248496
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	GPRASP1 LARP6 SPTB MLLT3 CD74 SEC31A MERTK QKI PIAS2 LCOR	7.43e-05	1285	61	10	35914814
Pubmed	Host cell factors stimulate HIV-1 transcription by antagonizing substrate-binding function of Siah1 ubiquitin ligase to stabilize transcription elongation factor ELL2.	MLLT3 HCFC1	8.42e-05	8	61	2	32479599
Pubmed	Covalent modification of p73alpha by SUMO-1. Two-hybrid screening with p73 identifies novel SUMO-1-interacting proteins and a SUMO-1 interaction motif.	CHD3 PIAS2	8.42e-05	8	61	2	10961991
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	ILF3 EP400 PRPF6 CHD7 MED1 HCFC1	8.42e-05	411	61	6	35182466
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	ELOA WDR70 CHD3 CHD7 MED1 PIAS2 HCFC1	9.29e-05	608	61	7	36089195
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ILF3 EP400 MAP4 AHNAK WDR70 PRPF6 CHD7 DHX33 SEC31A AHNAK2	1.14e-04	1353	61	10	29467282
Pubmed	rec-YnH enables simultaneous many-by-many detection of direct protein-protein and protein-RNA interactions.	MAP4 DHX33 MED1 QKI	1.16e-04	142	61	4	30217970
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	ARID1B ILF3 EP400 RPRD2 PRPF6 MED1	1.22e-04	440	61	6	34244565
Pubmed	BioID-based proteomic analysis of the Bid interactome identifies novel proteins involved in cell-cycle-dependent apoptotic priming.	MAP4 CHD3 AHNAK2	1.26e-04	55	61	3	33067418
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	ILF3 EP400 CHD7 HCFC1	1.29e-04	146	61	4	23892456
Pubmed	ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis.	ELOVL3 ELOVL2	1.35e-04	10	61	2	20937905
Pubmed	Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.	MAP7D2 LCOR	1.35e-04	10	61	2	19413330
Pubmed	Chromosomal localization of mouse Cenpa gene.	MSX1 YES1	1.35e-04	10	61	2	9605877
Pubmed	The mutation in Chd7 causes misexpression of Bmp4 and developmental defects in telencephalic midline.	MSX1 CHD7	1.35e-04	10	61	2	22658483
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	ARID1B ILF3 EP400 RPRD2 MED1 LCOR	1.43e-04	453	61	6	29656893
Pubmed	Impaired epidermal permeability barrier in mice lacking elovl1, the gene responsible for very-long-chain fatty acid production.	ELOVL3 ELOVL2	1.65e-04	11	61	2	23689133
Pubmed	MED1 is a lipogenesis coactivator required for postnatal adipose expansion.	ELOVL3 MED1	1.65e-04	11	61	2	33888555
Pubmed	An RNA-binding protein, Qki5, regulates embryonic neural stem cells through pre-mRNA processing in cell adhesion signaling.	QKI CNTN1	1.65e-04	11	61	2	29021239
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	EP400 AHNAK CHD3 CHD7 LCOR HCFC1	1.73e-04	469	61	6	27634302
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	ARID1B ILF3 EP400 RPRD2 SEC31A MED1	1.79e-04	472	61	6	38943005
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	SMG7 KIF26B RPRD2 SEC31A QKI PIAS2 LCOR	2.00e-04	689	61	7	36543142
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	ILF3 MAP4 AHNAK PRPF6 SEC31A HCFC1	2.28e-04	494	61	6	26831064
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	PRPSAP1 ILF3 PRPF6 DHX33 SEC31A YES1 HCFC1	2.28e-04	704	61	7	29955894
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	MAP4 AHNAK PCLO PRPF6 YES1 HCFC1	2.38e-04	498	61	6	36634849
Pubmed	O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry.	PCLO HCFC1	2.72e-04	14	61	2	16452088
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	TLK2 ELOA ARID1B ILF3 MYLK YES1 HCFC1	2.85e-04	730	61	7	34857952
Pubmed	Human mediator subunit MED26 functions as a docking site for transcription elongation factors.	ELOA MLLT3 MED1	2.93e-04	73	61	3	21729782
Pubmed	Cloning and characterization of 13 novel transcripts and the human RGS8 gene from the 1q25 region encompassing the hereditary prostate cancer (HPC1) locus.	SMG7 SHCBP1L	3.13e-04	15	61	2	11318611
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	ARID1B CHD7 MED1	3.56e-04	78	61	3	28611094
Pubmed	Periaxin is required for hexagonal geometry and membrane organization of mature lens fibers.	AHNAK CNTN1	3.57e-04	16	61	2	21745462
Pubmed	Delayed fusion and altered gene expression contribute to semicircular canal defects in Chd7 deficient mice.	MSX1 CHD7	3.57e-04	16	61	2	22705977
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	PRPSAP1 SMG7 WDR70 MLLT3 RPRD2 SEC31A KIAA1191 DENND4C	4.45e-04	1038	61	8	26673895
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	KIF26B KIAA0586 KIAA1191 DENND4C	5.06e-04	209	61	4	36779422
Pubmed	Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.	ELOA MED1	5.08e-04	19	61	2	19766566
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	ARID1B ILF3 AHNAK PCLO MYO16 RYR1 AHNAK2	5.19e-04	807	61	7	30575818
Pubmed	Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.	ILF3 MAP4 QKI	5.41e-04	90	61	3	23151878
Pubmed	The ULK1-FBXW5-SEC23B nexus controls autophagy.	FBXO16 SEC31A	5.63e-04	20	61	2	30596474
Pubmed	BAP1 maintains chromosome stability by stabilizing DIDO1 in renal cell carcinoma.	MAP4 HCFC1	5.63e-04	20	61	2	32509391
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	ELOA ARID1B ILF3 EP400 PRPF6 CHD7 SEC31A MED1	5.84e-04	1082	61	8	38697112
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	ARID1B EP400 PCLO CHD7 LCOR	6.73e-04	398	61	5	35016035
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	PRPSAP1 ILF3 SMG7 DENND4C	7.47e-04	232	61	4	25515538
Pubmed	Conserved beta-hairpin recognition by the GYF domains of Smy2 and GIGYF2 in mRNA surveillance and vesicular transport complexes.	PRPF6 SEC31A	7.48e-04	23	61	2	20696395
Pubmed	Elf5-centered transcription factor hub controls trophoblast stem cell self-renewal and differentiation through stoichiometry-sensitive shifts in target gene networks.	ILF3 CHD7 HCFC1	7.79e-04	102	61	3	26584622
Pubmed	Placentation defects are highly prevalent in embryonic lethal mouse mutants.	ARID1B NUBPL DENND4C	8.01e-04	103	61	3	29539633
Pubmed	Human transcription factor protein interaction networks.	ARID1B SMG7 EP400 RPRD2 CHD3 CHD7 QKI PIAS2 HCFC1	8.22e-04	1429	61	9	35140242
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	AHNAK CHD3 CHD7 PIAS2 DENND4C	8.38e-04	418	61	5	34709266
Pubmed	Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics.	PRPSAP1 MAP4 AHNAK PRPF6 AHNAK2	8.75e-04	422	61	5	27342126
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ELOA ILF3 LARP6 MYLK AHNAK PCLO MAP7D2 CHD3 PRPF6	8.77e-04	1442	61	9	35575683
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ARID1B CHD7 MED1 PIAS2 RYR1 AHNAK2	8.78e-04	638	61	6	31182584
Pubmed	P300 Interacted With N-Myc and Regulated Its Protein Stability via Altering Its Post-Translational Modifications in Neuroblastoma.	EP400 HCFC1	8.84e-04	25	61	2	36708875
Pubmed	ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes.	ILF3 PRPF6 MED1	8.95e-04	107	61	3	20508642
Pubmed	SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.	ILF3 EP400 AHNAK DHX33	9.15e-04	245	61	4	35652658
Pubmed	Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity.	ELOA PRPF6	9.57e-04	26	61	2	33298525
Pubmed	Identification by proximity labeling of novel lipidic and proteinaceous potential partners of the dopamine transporter.	CD74 MYO16	1.03e-03	27	61	2	34709416
Pubmed	MxA interacts with and is modified by the SUMOylation machinery.	KIF26B CHD3	1.03e-03	27	61	2	25447205
Interaction	GJB7 interactions	PTPRG AHNAK YES1 CNTN1 AHNAK2	6.16e-07	56	59	5	int:GJB7
Interaction	SMC5 interactions	ELOA ARID1B ILF3 EP400 MAP4 AHNAK RPRD2 CHD3 PRPF6 CHD7 MED1 LCOR HCFC1	4.93e-06	1000	59	13	int:SMC5
Interaction	MED21 interactions	ELOA PTPRG RPRD2 MED1 YES1 CNTN1	7.00e-06	159	59	6	int:MED21
Interaction	SUMO2 interactions	MSX1 EP400 MAP4 AHNAK CHD3 PRPF6 MERTK PIAS2 HCFC1 AHNAK2	7.51e-06	591	59	10	int:SUMO2
Interaction	CERS2 interactions	PTPRG AHNAK ELOVL3 YES1 ELOVL2 CNTN1 AHNAK2	7.97e-06	249	59	7	int:CERS2
Interaction	PML interactions	TLK2 SAP25 ILF3 EP400 MAP4 AHNAK WDR70 PRPF6 MED1 PIAS2 HCFC1 AHNAK2	1.35e-05	933	59	12	int:PML
Interaction	MED26 interactions	ELOA MLLT3 RPRD2 MED1 QKI	1.53e-05	107	59	5	int:MED26
Interaction	PCDHGC3 interactions	PTPRG AHNAK YES1 CNTN1	1.88e-05	54	59	4	int:PCDHGC3
Interaction	NAA40 interactions	ELOA ILF3 SMG7 EP400 MAP4 AHNAK WDR70 RPRD2 CHD3 MED1 HCFC1 AHNAK2	2.16e-05	978	59	12	int:NAA40
Interaction	CTBP1 interactions	EP400 PCLO CHD3 PRPF6 SEC31A MED1 PIAS2 LCOR	2.29e-05	406	59	8	int:CTBP1
Interaction	AR interactions	ARID1B EP400 RPRD2 CHD3 PRPF6 CHD7 MED1 YES1 PIAS2 LCOR HCFC1 STAP1	2.48e-05	992	59	12	int:AR
Interaction	SP7 interactions	ARID1B EP400 RPRD2 CHD3 CHD7 QKI PIAS2	2.89e-05	304	59	7	int:SP7
Interaction	JSRP1 interactions	AHNAK YES1 AHNAK2	3.05e-05	21	59	3	int:JSRP1
Interaction	HDAC2 interactions	ELOA SAP25 ILF3 EP400 MAP4 AHNAK RPRD2 CHD3 HCFC1 DENND4C AHNAK2	3.62e-05	865	59	11	int:HDAC2
Interaction	PAX9 interactions	MSX1 ARID1B CHD7 QKI PIAS2	3.92e-05	130	59	5	int:PAX9
Interaction	ZNF330 interactions	ELOA ILF3 CHD3 PRPF6 CHD7 DHX33 PIAS2 LCOR	4.46e-05	446	59	8	int:ZNF330
Interaction	PHLPP1 interactions	MAP4 KIF26B AHNAK CHD3 HCFC1 DENND4C AHNAK2	5.15e-05	333	59	7	int:PHLPP1
Interaction	XRCC6 interactions	ELOA ILF3 EP400 MAP4 WDR70 RPRD2 CHD3 CHD7 MED1 PIAS2 HCFC1	6.84e-05	928	59	11	int:XRCC6
Interaction	POLR1G interactions	ELOA EP400 WDR70 RPRD2 PRPF6 CHD7 DHX33 LCOR	8.49e-05	489	59	8	int:POLR1G
Interaction	ASF1A interactions	TLK2 ARID1B EP400 CHD7 LCOR HCFC1	8.73e-05	249	59	6	int:ASF1A
Interaction	PARP1 interactions	PRPSAP1 ELOA ILF3 EP400 WDR70 CHD3 PRPF6 CHD7 DHX33 SEC31A MERTK MED1 PIAS2	8.88e-05	1316	59	13	int:PARP1
Interaction	GRM8 interactions	GPRASP1 PIAS2	1.25e-04	6	59	2	int:GRM8
Interaction	EGR2 interactions	ARID1B EP400 CHD7 PIAS2 HCFC1	1.43e-04	171	59	5	int:EGR2
Interaction	H2BC21 interactions	ARID1B ILF3 EP400 AHNAK PCLO RPRD2 CHD7 LCOR HCFC1	1.78e-04	696	59	9	int:H2BC21
Interaction	SUPT5H interactions	ELOA ARID1B EP400 WDR70 RPRD2 CHD3 CHD7	1.82e-04	408	59	7	int:SUPT5H
Interaction	TERF2IP interactions	ELOA EP400 WDR70 CHD3 CHD7 KIAA1191 MED1 HCFC1	1.95e-04	552	59	8	int:TERF2IP
Interaction	PRRC2C interactions	ILF3 AHNAK CD74 CHD3 LCOR HCFC1	2.00e-04	290	59	6	int:PRRC2C
Interaction	CEBPA interactions	TLK2 ARID1B ILF3 EP400 MAP4 CHD3 PRPF6 CHD7 MED1 QKI LCOR HCFC1	2.19e-04	1245	59	12	int:CEBPA
Interaction	PPIA interactions	ARID1B ILF3 PTPRG EP400 AHNAK RPRD2 SEC31A MED1 PIAS2 HCFC1	2.31e-04	888	59	10	int:PPIA
GeneFamily	Fibronectin type III domain containing	MYLK PTPRG MERTK CNTN1	2.50e-04	160	35	4	555
GeneFamily	PDZ domain containing	AHNAK PCLO AHNAK2	3.13e-03	152	35	3	1220
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	MYLK MERTK CNTN1	3.68e-03	161	35	3	593
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	EP400 CHD7	4.72e-03	53	35	2	532
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	HCFC1 MYO16 RYR1	5.10e-03	181	35	3	694
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#4	PCLO MAP7D2 CHD7 QKI LCOR ELOVL2	2.68e-06	137	61	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	TLK2 PCLO KIAA0586 MAP7D2 RPRD2 PRPF6 CHD7 QKI PIAS2 ELOVL2	6.89e-06	595	61	10	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500	MSX1 KIF26B PCLO KIAA0586 PRPF6 CHD7 KIAA1191 MERTK ELOVL2	1.06e-05	492	61	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000	PRPSAP1 TLK2 ILF3 PCLO MAP7D2 PRPF6 CHD7 KIAA1191 QKI PIAS2 LCOR ELOVL2	1.86e-05	979	61	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	PCLO KIAA0586 MAP7D2 CHD7 QKI YES1 ELOVL2	2.28e-05	298	61	7	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
CoexpressionAtlas	DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#2_top-relative-expression-ranked_1000	TLK2 MAP7D2 SHCBP1L LCOR	2.49e-05	59	61	4	gudmap_developingGonad_e16.5_testes_1000_k2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#4	ILF3 PCLO MAP7D2 QKI LCOR ELOVL2	4.52e-05	225	61	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500	TLK2 MSX1 PRSS37 MAP7D2 CHD3 PRPF6 CHD7 MERTK	7.87e-05	492	61	8	Facebase_RNAseq_e10.5_Mandibular Arch_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	ILF3 LARP6 MYLK PTPRG MAP4 KIF26B RAPGEF5 MED1 YES1 CNTN1	1.03e-04	818	61	10	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5	TLK2 ELOA PCLO KIAA0586 MAP7D2 MLLT3 PRPF6 CHD7 QKI ELOVL2	1.18e-04	831	61	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4	PCLO MAP7D2 CHD7 ELOVL2	1.82e-04	98	61	4	Facebase_RNAseq_e10.5_Olfactory Pit_500_K4
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#1_top-relative-expression-ranked_500	MAP7D2 SHCBP1L LCOR	1.92e-04	39	61	3	gudmap_developingGonad_e16.5_ovary_500_k1
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	PCLO KIAA0586 PRPF6 CHD7 ELOVL2	2.26e-04	192	61	5	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4	TLK2 KIAA0586 PRPF6 CHD7 PIAS2	2.93e-04	203	61	5	Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5	PCLO MAP7D2 MLLT3 CHD7 ELOVL2	3.00e-04	204	61	5	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#2	PCLO MAP7D2 CHD3 CHD7 ELOVL2	3.42e-04	210	61	5	Facebase_RNAseq_e9.5_Olfactory Placode_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#3	PCLO MAP7D2 CHD7 ELOVL2	3.70e-04	118	61	4	Facebase_RNAseq_e8.5_Floor Plate_500_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	TLK2 MSX1 KIF26B PRSS37 MAP7D2 CD74 CHD3 PRPF6 CHD7 MERTK	4.36e-04	978	61	10	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#4	MAP7D2 MLLT3 CHD7 ELOVL2	4.47e-04	124	61	4	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000	MSX1 ELOA KIF26B PCLO KIAA0586 PRPF6 CHD7 KIAA1191 MERTK ELOVL2	4.61e-04	985	61	10	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	TLK2 SMG7 PCLO KIAA0586 MAP7D2 MLLT3 PRPF6 CHD7 QKI ELOVL2	4.76e-04	989	61	10	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID1B RAPGEF5 CD74 CHD7 STAP1	8.02e-06	200	61	5	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK CD74 ELOVL2 STAP1	5.92e-05	154	61	4	1e088b0d4a44267f46a9b643f46a1aba784686b1
ToppCell	facs-Brain_Myeloid-Cortex_-18m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK CD74 STAP1 RYR1	6.22e-05	156	61	4	2ba838bc864c2c1767bcab7bb4d790af96b91387
ToppCell	mild_COVID-19_(asymptomatic)-B_cell\|World / disease group, cell group and cell class (v2)	ENKUR MYLK SPTB NUBPL	6.54e-05	158	61	4	afa8fa21c39c2192c1e23a4660011d63d58b733f
ToppCell	facs-Brain_Myeloid-Cerebellum-3m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK CD74 C17orf107 STAP1	6.70e-05	159	61	4	323cb4a2416d2e6bff0a3f225d2edeae9ab7dc76
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AHNAK CD74 STAP1 RYR1	6.86e-05	160	61	4	1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5
ToppCell	facs-Trachea-3m-Hematologic-myeloid-tracheal_macrophage-macrophage_of_tracheal_l15\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CD74 CHD7 STAP1 RYR1	7.55e-05	164	61	4	5ca7b69684a8bb12dd0b45e7ad94e30d16ed01ce
ToppCell	TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8\|TCGA-Thryoid / Sample_Type by Project: Shred V9	PTPRG RAPGEF5 MERTK PLEKHA8P1	8.29e-05	168	61	4	00646601548b0fee42ae16bfa5e93603bc7c5129
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	GPRASP1 AHNAK PRPF6 SEC31A	9.92e-05	176	61	4	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Brain_Myeloid-Striatum-24m-Myeloid-macrophage\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SAP25 AHNAK CD74 STAP1	1.01e-04	177	61	4	f6b9d91d46830d0d207b0abd4ee5a4942fd99774
ToppCell	3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MSX1 MYLK RAPGEF5 YES1	1.01e-04	177	61	4	16197068260fc062bf8b730a51a199887ea580b9
ToppCell	FF-Differ-KC\|World / shred by cell class for mouse tongue	MSX1 KIF26B PCLO RYR1	1.06e-04	179	61	4	1526a130565a97c291a25a7a988089bffc1515c1
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF150 MYLK CNTN1 AHNAK2	1.15e-04	183	61	4	61a73de857f4ae02dcba3af348f436f602b28ff2
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B PCLO MYO16 CNTN1	1.18e-04	184	61	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B PCLO MYO16 CNTN1	1.18e-04	184	61	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIF26B PCLO MYO16 CNTN1	1.18e-04	184	61	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK SHCBP1L MYO16 STAP1	1.31e-04	189	61	4	aba941ba6ce7702418b3f470bde573d123c4aade
ToppCell	Control-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	PTPRG RAPGEF5 MLLT3 YES1	1.39e-04	192	61	4	1bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID1B CD74 CHD7 STAP1	1.39e-04	192	61	4	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK SHCBP1L MYO16 STAP1	1.39e-04	192	61	4	690cf19e9b0b2ada80097c63eae827529aa5b6f3
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRG RAPGEF5 QKI YES1	1.39e-04	192	61	4	4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK SHCBP1L MYO16 STAP1	1.39e-04	192	61	4	3d6c4c5847ca1e44fa380403d25af45d5b51ee9b
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK SHCBP1L MYO16 STAP1	1.39e-04	192	61	4	e0412964a3ee1bf3c0ef64f9a6f20f7e7835701e
ToppCell	5'-Airway_Nasal-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	AHNAK SHCBP1L MYO16 STAP1	1.39e-04	192	61	4	b5871247a5f3e970fa05b33fff21bef9d2ab5741
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LARP6 MYLK RAPGEF5 QKI	1.39e-04	192	61	4	3ce5dbde41aeb73d49f2c7991d34682f0827fa5a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LARP6 MYLK RAPGEF5 QKI	1.39e-04	192	61	4	8dc3016601148243196e925641c9507e9d58c9e0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID1B CD74 CHD7 STAP1	1.41e-04	193	61	4	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	distal-Hematologic-Basophil/Mast_2-3\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPTB C17orf107 STAP1 AHNAK2	1.41e-04	193	61	4	f22d0a2ea6bbdd625909ccb6a89aca89ab670306
ToppCell	Control-Myeloid-Monocyte-derived_macrophages\|Control / group, cell type (main and fine annotations)	RNF150 CD74 MERTK RYR1	1.41e-04	193	61	4	a6b3bd01e585e2e3fbe9bf693a2e385773123f8e
ToppCell	distal-Hematologic-Basophil/Mast_2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPTB C17orf107 STAP1 AHNAK2	1.41e-04	193	61	4	dcdc1498726c68bf590bf84cb81e5f7fb7ba4d78
ToppCell	Immune-interstitial_macrophage_(C1Q_positive)\|World / Lineage, Cell type, age group and donor	RNF150 CD74 MERTK RYR1	1.41e-04	193	61	4	64d598162a256ac6c9f8280c8a9133661dfbb10f
ToppCell	distal-3-Hematologic-Basophil/Mast_2\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SPTB C17orf107 STAP1 AHNAK2	1.41e-04	193	61	4	23c6c798525dad43eff792727902ea562bf373be
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ARID1B CD74 CHD7 STAP1	1.41e-04	193	61	4	f4135615ee0118eec9e221becdd67888e0c2a112
ToppCell	Healthy_donor-B_naive\|World / disease group, cell group and cell class (v2)	RAPGEF5 CD74 CHD7 STAP1	1.47e-04	195	61	4	c66bbfdf0091cc62aa50edfa88820bbda191b7bb
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CD74 MERTK DENND4C RYR1	1.47e-04	195	61	4	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	facs-Lung-nan-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PTPRG RAPGEF5 QKI YES1	1.47e-04	195	61	4	7f9b7f15006610ad591063d90e90367bd6083c7f
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ARID1B PTPRG WDR70 MLLT3	1.50e-04	196	61	4	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	Healthy_donor-B_naive\|Healthy_donor / disease group, cell group and cell class (v2)	RAPGEF5 CD74 CHD7 STAP1	1.50e-04	196	61	4	cf254b1466357984201595fa32408d659eb741ef
ToppCell	Healthy/Control-B_naive\|World / Disease group and Cell class	RAPGEF5 CD74 CHD7 STAP1	1.50e-04	196	61	4	ec935a4e16495c87b17070eb13c1e28bdb64e7ee
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG7 MAP4 SEC31A QKI	1.50e-04	196	61	4	151f1a29a91f8b234e9b6ed062666357a2f69128
ToppCell	COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	GPRASP1 MLLT3 CHD3 CHD7	1.53e-04	197	61	4	836dd8110d5689f944ad1d301def38c32278b5b5
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	TLK2 RNF150 PCLO STAP1	1.56e-04	198	61	4	62059185afdf66126a6fbc899ce611c47e7a0feb
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LARP6 MYLK GAL3ST1 RAPGEF5	1.56e-04	198	61	4	bdabdb11217ea16e5863aa6bfb0f04d48b17f81e
ToppCell	Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	RNF150 MYLK SPTB CNTN1	1.56e-04	198	61	4	1e1ea54f0c234f3b6d29064c4881d8a0c0949a75
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RNF150 CD74 MERTK RYR1	1.62e-04	200	61	4	179afc4bee7a2fd85a3b5dadf32544a63807c164
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	RNF150 CD74 MERTK RYR1	1.62e-04	200	61	4	ad52b38df5c71f28829b04cd0e6b97f0f9f7610a
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Cortical_neuron\|5w / Sample Type, Dataset, Time_group, and Cell type.	C22orf42 MAP4 LCOR CNTN1	1.62e-04	200	61	4	085060d148158f7d9e938b6c4a3700ccbb3bca15
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LARP6 MYLK RAPGEF5 QKI	1.62e-04	200	61	4	3ce8a2db8c25e1169a0a544f644a63104749c5ee
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYLK MAP4 RAPGEF5 AHNAK	1.62e-04	200	61	4	79e51afb57ca38aacebd0298e5e727b55c0cfff9
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TLK2 ARID1B AHNAK QKI	1.62e-04	200	61	4	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	mild-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID1B CD74 CHD7 STAP1	1.62e-04	200	61	4	fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LARP6 MYLK GAL3ST1 RAPGEF5	1.62e-04	200	61	4	0bfd41c12887479ceb62c3db0a3c3ba5007eb62b
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LARP6 MYLK GAL3ST1 RAPGEF5	1.62e-04	200	61	4	159377d904394d91e09913131e9a93e08189955a
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	LARP6 MYLK GAL3ST1 RAPGEF5	1.62e-04	200	61	4	d30316836494f33ca46d4e415fd2ed179e9cb5ee
ToppCell	mild-B_naive\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	RAPGEF5 CD74 CHD7 STAP1	1.62e-04	200	61	4	d0467cab6a42bf780aa49046bf3231ca161dc144
Computational	Neighborhood of CDC2L5	MSX1 EP400 KIAA0586 CHD3 SEC31A PIAS2	1.95e-05	142	43	6	MORF_CDC2L5
Computational	Neighborhood of ATRX	MSX1 EP400 KIAA0586 CHD3 SEC31A PIAS2	1.96e-04	215	43	6	MORF_ATRX
Drug	Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A	GPRASP1 EP400 AHNAK PCLO CHD3 QKI	1.22e-05	191	61	6	4168_DN
Drug	Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; PC3; HT_HG-U133A	ILF3 SMG7 RAPGEF5 RPRD2 QKI HCFC1	1.37e-05	195	61	6	4644_DN
Drug	Drofenine hydrochloride [548-66-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A	GPRASP1 KIAA0586 MLLT3 CHD3 NUBPL ELOVL2	1.45e-05	197	61	6	3455_DN
Drug	Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A	SMG7 MLLT3 RPRD2 CHD3 QKI ELOVL2	1.58e-05	200	61	6	3432_DN
Disease	uveal melanoma disease severity	WDR70 STAP1	7.92e-05	7	58	2	EFO_0010244
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	AHNAK MERTK RYR1 FAAH2	2.09e-04	148	58	4	C0279702
Disease	S-6-hydroxywarfarin measurement	PTPRG PCLO MLLT3 YES1 DENND4C	7.82e-04	368	58	5	EFO_0803326
Disease	osteoarthritis	MYLK PTPRG KIF26B RPRD2	9.63e-04	222	58	4	MONDO_0005178
Disease	sensory perception of bitter taste	RNF150 PRSS37	1.20e-03	26	58	2	GO_0050913

Protein segments in the cluster

Peptide	Gene	Start	Entry
KRPEMPSKKPMSRGD	PTPRG	691	P23470
DLMKMTAGKRSPPIK	EP400	2466	Q96L91
KIVPKMAFKEPKPMS	MLLT3	246	P42568
MAFKEPKPMSKEPKP	MLLT3	251	P42568
LKMPKMKMPTFSTPG	AHNAK	626	Q09666
KLPDMSVKTPKISMP	AHNAK	686	Q09666
GPDWNLKMPKIKMPK	AHNAK	991	Q09666
LKMPKIKMPKFSMPS	AHNAK	996	Q09666
IPKMKMPKFSMPSLK	AHNAK	1126	Q09666
GPKFKMPEMSIKPQK	AHNAK	1436	Q09666
MPKLNIKAPKVSMPD	AHNAK	1771	Q09666
PEGKLKGPKLKMPEM	AHNAK	2096	Q09666
GPDWHLKMPKVKMPK	AHNAK	2631	Q09666
LKMPKVKMPKFSMPG	AHNAK	2636	Q09666
MPKIKMPKISMPGFK	AHNAK	2766	Q09666
PKIKMPKISMPGFKG	AHNAK	3151	Q09666
QGPDWHLKMPKVKMP	AHNAK	3796	Q09666
KMPKIKMPKISMPGF	AHNAK	3931	Q09666
GPDWHLKMPKVKMPK	AHNAK	4181	Q09666
LKMPKVKMPKFSMPG	AHNAK	4186	Q09666
PKFKMPEMNIKAPKI	AHNAK	4371	Q09666
GPKFKMPEMSIKAPK	AHNAK	4706	Q09666
MMSPGESKLPLPLKA	ARID1B	1086	Q8NFD5
LPKTPKMLKMSKGLD	C22orf42	66	Q6IC83
KKMGGAMAPPMKDLP	CHD7	2656	Q9P2D1
MPPGKVLQPVLKMKV	PPP2R3B	1	Q9Y5P8
MVGEMETKEKPKPTP	QKI	1	Q96PU8
MTKMPSALGKLPGLK	LRRC69	26	Q6ZNQ3
KPANKRPMSSPEMKS	HCFC1	2011	P51610
KPMGNAKPAETLKPM	MYLK	1036	Q15746
KMDLAPSKDMGPPKE	MAP4	361	P27816
IKMDLAPSKDMGPPK	MAP4	386	P27816
MSLPKPTEPPMNKRL	MAP7D2	171	Q96T17
SQGIPKPMVILPFMK	MERTK	661	Q12866
MSGSTKPEQVKLMPP	MYO16	386	Q9Y6X6
TPPVGMSPQVLKKSM	KIF26B	1126	Q2KJY2
KMSPKPDAKPMPKGS	PCLO	861	Q9Y6V0
PPKKKMKLMRSEGPD	LCOR	396	Q96JN0
MKAVLIGMKPPKKKP	LARP6	286	Q9BRS8
MLIKLAKPAMLNPKV	PRSS37	101	A4D1T9
KPPKMDIPVMEGKKQ	KIAA1191	271	Q96A73
VKNNPKKPEMPNMLE	MTFR1	226	Q15390
MLPPQKKPWESMAKG	GAL3ST1	1	Q99999
DPRKPTVKKIAPMMA	ELOA	771	Q14241
TLKAANVKPPKMLPM	ELOVL3	186	Q9HB03
PMKKDMQEPPAGKEV	ELOVL2	261	Q9NXB9
PLIAKKNPKIPMSKM	CHD3	171	Q12873
LAPTFEMNPMKKKIL	CNTN1	411	Q12860
LKSLEPPEPKMQGML	C17orf107	51	Q6ZR85
HKVLGMDPLPSKMPK	ILF3	331	Q12906
MDPLPSKMPKKPKNE	ILF3	336	Q12906
TPMGRKMAAFPLEPK	DHX33	491	Q9H6R0
KPINLLSQQMKPGMK	DENND4C	1826	Q5VZ89
MKTMGPAKVEVPSPK	ENKUR	46	Q8TC29
PMLKVMAGPGIKRLK	FAAH2	281	Q6GMR7
PGLELPLMMAKEKPP	PRPSAP1	226	Q14558
PLMMAKEKPPITVVG	PRPSAP1	231	Q14558
KLPKPPKPVSKMRMA	CD74	96	P04233
PPKNTDGPKMQTKMS	FBXO16	6	Q8IX29
PPPSAMMNLEKKPAK	RPRD2	841	Q5VT52
KAKKVAMMTQPPATP	RYR1	1391	P21817
KMKPQGKPSSLMNPS	MED1	1171	Q15648
PSVPKMMNLKGNPEL	NUBPL	111	Q8TB37
PMRPKKEAMKVSSQP	PIAS2	426	O75928
PMCKMNILKALGIPP	RNF150	316	Q9ULK6
IMPGARPKNKSKVMP	GPRASP1	46	Q5JY77
KAPQQMMGSLKLLPP	SAP25	101	Q8TEE9
PGSPQLAMLKSSKMK	PLEKHA8P1	71	O95397
EKLKMAAKPMLPPAA	MSX1	236	P28360
MNKKKKPFLGMPAPL	PRPF6	1	O94906
QQQPLEKKMKPFPME	SMG7	841	Q92540
FKKMKPPKIPFMPLL	RAPGEF5	486	Q92565
GVNMKVLPAPKLKMT	SHCBP1L	566	Q9BZQ2
MLAKRKPPAMGQAPP	TLK2	341	Q86UE8
MPSFKMPKVDLKGPQ	AHNAK2	921	Q8IVF2
LPKVEMPSFKMPKVA	AHNAK2	1081	Q8IVF2
MPSFKMPKVALKGPQ	AHNAK2	1086	Q8IVF2
LPKVQMPSLKMPKVD	AHNAK2	1246	Q8IVF2
MPSLKMPKVDLKGPQ	AHNAK2	1251	Q8IVF2
LPKVQMPSFKMPKVD	AHNAK2	1576	Q8IVF2
MPSFKMPKVDLKGPQ	AHNAK2	1581	Q8IVF2
LPKVQMPSLKMPKVA	AHNAK2	1741	Q8IVF2
MPSLKMPKVALKGPQ	AHNAK2	1746	Q8IVF2
LPKVDMPSFKMPKVD	AHNAK2	1906	Q8IVF2
MPSFKMPKVDLKGPQ	AHNAK2	1911	Q8IVF2
MPSLKMPKVDLKGPQ	AHNAK2	2076	Q8IVF2
LPKLQMPSFKMPKVD	AHNAK2	2401	Q8IVF2
MPSFKMPKVDLKGPQ	AHNAK2	2406	Q8IVF2
MPSFKMPEVDLKGPQ	AHNAK2	2736	Q8IVF2
LPKVQMPSFKMPKVD	AHNAK2	2896	Q8IVF2
MPSFKMPKVDLKGPQ	AHNAK2	2901	Q8IVF2
LPKLQMPSFKMPKVD	AHNAK2	3061	Q8IVF2
MPSFKMPKVDRKGPQ	AHNAK2	3066	Q8IVF2
LPKLQMPSFKMPKVD	AHNAK2	3226	Q8IVF2
MPSFKMPKVDRKGPQ	AHNAK2	3231	Q8IVF2
MPSFKMPKVDLKSPQ	AHNAK2	3396	Q8IVF2
MPSLKMPKVDLKGPQ	AHNAK2	3726	Q8IVF2
LPKVQMPSFKMPKVD	AHNAK2	3886	Q8IVF2
MPSFKMPKVDLKGPE	AHNAK2	3891	Q8IVF2
LPKVQMPSFKMPKVD	AHNAK2	4051	Q8IVF2
MPSFKMPKVDLKGPQ	AHNAK2	4056	Q8IVF2
LPKVQMPCLKMPKVA	AHNAK2	4216	Q8IVF2
MPCLKMPKVALKGPQ	AHNAK2	4221	Q8IVF2
MPSFKMPKVDLKGPQ	AHNAK2	4551	Q8IVF2
PLPPKMVGKPVNFME	WDR70	121	Q9NW82
MMAKKPPKPAPRRIF	STAP1	1	Q9ULZ2
KPVMPKEMVPLGDSN	TEX13C	361	A0A0J9YWL9
SLKKDPVMPQNMIPL	TEX13C	546	A0A0J9YWL9
LKKVPVMPKEMVPLG	TEX13C	631	A0A0J9YWL9
SGEMLPKPTKGKMRI	SPTB	96	P11277
KKKKMPENFMPPVPI	SEC31A	1006	O94979
KAVPLSASQMPPAKM	KIAA0586	1486	Q9BVV6
KVAIKTLKPGTMMPE	YES1	301	P07947